(E)-(2-((HYDROXYIMINO)METHYL)PHENYL)BORONIC ACID, 95%, 250mg

Hexahydrohippuric acid, 98%, 25g

(R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine, 95.0%, 250mg

(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, 98%, 10g

(R)-Morpholin-2-ylmethanol hydrochloride, 95.0%, 250mg

2-Bromo-3-iodo-4-methylpyridine, 95+%, 250mg

3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-nitro-1H-indole, 97.0%, 250mg

3-(5,5-dimethyl-5,6-dihydro[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)phenol, 95.0%, 5g

Nd-Z-D-ornithine methyl ester hydrochloride, 99.0%, 1g

Dimethyl 4-Acetoxyisophthalate>98.0%(GC)1g

2-Chloro-3-methyl-quinoxaline, 97.0%, 1g

5-(chloromethyl)-4-methyl-1,2,3-thiadiazole, 95.0%, 5g

N-(2-Fluorophenyl)-N'-[2-methoxy-5-(trifluoromethyl)phenyl]urea, 98%, 250mg